Pharma in Healthcare
Pharma in Healthcare
Abbott receives FDA approval for new CardioMEMS HF system capabilities that help patients engage in the care of their heart condition
The US Food and Drug Administration (FDA) has approved for Abbott’s updates to the CardioMEMS HF System that enable new patient-facing capabilities through the...
Pharma in Healthcare
American Regent issues voluntary nationwide recall of three lots of epinephrine injection, due to the presence of particulate matter and lack of assurance of...
American Regent is conducting a nationwide voluntary recall of three lots of epinephrine injection, USP 30 mg/30 mL (1 mg/mL) multi dose vials to the...
Pharma Lab news
Roche expands cyclospora testing portfolio to support US public health response
As a cyclospora outbreak continues to spread throughout the United States, Roche, in collaboration with subsidiary TIB MOLBIOL, has made available two new flexible and...
Pharma in Healthcare
Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
The European Commission (EC) has approved an extension of the indication for Sanofi’s MenQuadfi (meningococcal Group A, C, W and Y conjugate vaccine) to...
Pharma in Healthcare
Nipro Corporation receives FDA 510(k) clearance for Elisio-HX, introducing HDs to the United States
Nipro Corporation has been granted 510(k) clearance for the Elisio-HX dialyser by the United States Food and Drug Administration (FDA).
The clearance enables the introduction...
Drug Delivery and Supply Chain
European Commission authorises Pfizer and BioNTech XFG-adapted COVID-19 vaccine in the European Union
Pfizer and BioNTech SE have been granted marketing authorisation by the European Commission (EC) for the companies’ 2026-2027 COVID-19 vaccine formula, targeting the XFG...
Pharma in Healthcare
IBSA foundation fellowships shatter records with unprecedented global reach and opens 2026 call
IBSA Foundation (Institut Biochimique SA) for scientific research, recently announced a record-shattering year for its prestigious fellowship programme, drawing an unprecedented 398 applications from 64 countries....
Pharma in Healthcare
Acute myocardial infarction market is expected to hit growth stride at a CAGR of 13% during the forecast period (2026-2036) with new therapeutic innovations
Recently published acute myocardial infarction market insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
